Healthleap secured $38 million to scale its clinical AI platform that runs inside electronic health records. The company’s screening system targets conditions that may otherwise go undiagnosed in hospitalized patients, with the goal of helping clinicians catch risks earlier and intervene sooner. The financing highlights ongoing demand for applied AI tools that integrate into care workflows—especially where clinicians face high alert loads and uneven follow-up. For hospitals and partners, the focus will be on performance generalization, alert tuning, and how screening results translate into measurable clinical outcomes. In the near term, market watchers will likely track Healthleap’s deployment growth and whether the company expands to additional use cases beyond initial supported indications.